DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/w3csvv/genotyping_market) has announced the addition of the "Genotyping Market by Technology, Application & by Products - Global Forecast to 2020" report to their offering.
The global genotyping market is expected to grow at a CAGR of 22.3% during the forecast period of 2015 to 2020 to reach $17.0 billion in 2020.
Genotyping tests are increasingly being used in drug discovery and development process and to provide personalized therapy, factors that are driving market growth. In addition to this, heavy investments by key manufacturers to offer advanced and innovative products for wider applications are also propelling market growth.
Genotyping is used to study genetic variation in the genotypes of living organisms, including humans, animals, plants, and microorganisms. The genotyping market is mainly driven by technological advancements, increasing incidence of genetic diseases and awareness on personalized medicine, decreasing prices of DNA sequencing, growing importance of SNP genotyping in drug development, and the growing demand for genotyping of animal and plant livestock. However, ambiguity in the reimbursement for these products and a lack of well-trained lab technicians are drivers expected to restrain the growth of this market in the forecast period.
The market in this report is broadly segmented based on products and services, technology, applications, and end users. The market, by technology, is segmented into microarrays, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, allele specific oligonucleotide (ASO) probes, and others (in situ hybridization). Sequencing market is forecasted to grow at a highest CAGR 27.7% over the forecast period of 2015-2020, owing to its high speed, accuracy, flexibility, and increasing application areas.
Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The high growth in this segment is attributed to increasing use of genotyping in drug development process & to analyze the effects of drug.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Insights
7 Genotyping Market, By Product and Services
8 Genotyping Market, By Technology
9 Genotyping Market, By Application
10 Genotyping Market, By End-User
11 Genotyping Market, By Region
12 Competitive Landscape
13 Company Profiles
- Affymetrix, Inc
- Agilent Technologies
- Beckman Coulter
- Fluidigm Corp.
- GE Healthcare
- Illumina, Inc
- Life Technologies Corporation (Thermofisher Scientific)
- Qiagen NV
- Roche
- Sequenom Inc.
For more information visit http://www.researchandmarkets.com/research/w3csvv/genotyping_market
